Episode 6: Non-Muscle Invasive Bladder Cancer Innovations
Medscape,
This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion.
This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion.
Cancer diagnostics company Nonagen Bioscience has received a CE mark for their bladder cancer diagnostic test, Oncuria…
LOS ANGELES, June 16, 2022 /PRNewswire/— Nonagen Bioscience, a cancer diagnostics company, today announced CE marking for its…
LOS ANGELES, June 16, 2022 /PRNewswire/Nonagen Bioscience, a cancer diagnostics company, today announced CE marking for its…